Welcome to
Allurion’s Blog

January 24, 2018

Two Gastric Balloons Approved By FDA

In a landmark month for obesity devices, the ReShape Integrated Dual Balloon System and the Orbera Gastric Balloon were both approved by the US FDA for use in obese individuals. While the approval of these two balloons represents a critical step forward for the treatment of obesity in the United States, the devil may be in the details. But first, the good stuff: both balloons have been shown to lead to more weight loss than just dieting in large, well-designed clinical trials. Moreover, participants in the ReShape FDA study who were followed for 6 months after their balloons were removed…

January 24, 2018

Elipse System Receives European Marketing Approval

Today, we are happy to announce that the Elipse System has received European marketing approval! The Elipse Balloon is now available for sale in select centers in Europe. Please read the press release for more details.

January 24, 2018

Obesity is Complex. Why Aren’t its Treatments?

In a recent article on MedCityNews, Dr. Shantanu Gaur and Michael Fergusson (CEO of Ayogo) explore the next generation of more personalized obesity treatments. Click here for the article.

January 24, 2018

Allurion Technologies’ Elipse Intragastric Balloon Receives Prestigious SAGES Innovation Award

Allurion Technologies announced today that its flagship product, the Elipse Balloon, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). The Elipse Device is the world’s first procedureless™ intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is the first intragastric balloon to receive this award. The Elipse System received European Union CE marking in late 2015 and is now available at leading weight loss centers in the United Kingdom, Italy and France. Plans for commercial expansion within Europe and in the Middle East are underway. For the…

January 24, 2018

Elipse Balloon Multi-Center Study Published

We are pleased to announce the publication of our European multi-center trial results in Endoscopy! Thank you to our European investigators and patients who participated in a groundbreaking study on the Elipse Balloon.

January 24, 2018

Why Stomach Balloons are the Future of Healthcare

The rise of the balloon field is not only revolutionizing obesity but also emblematic of shifts occurring in healthcare systems all around the world. Dr. Shantanu Gaur explores these themes in his latest post on MedCityNews. Click here for the full post.

August 22, 2017

Allurion’s Shantanu Gaur on Jim Cramer’s Mad Money

Allurion Technologies founder discusses his company’s non-invasive ‘balloon’ pill that helps treat obesity from CNBC.

June 8, 2017

Why Stomach Balloons are the Future of Healthcare

The rise of the balloon field is not only revolutionizing obesity but also emblematic of shifts occurring in healthcare systems all around the world. Dr. Shantanu Gaur explores these themes in his latest post on MedCityNews. Click here for the full post.

April 3, 2017

Allurion Repays Massachusetts Life Sciences Center

5 years ago, the Massachusetts Life Sciences Center​ awarded us an Accelerator Loan that made the R&D and clinical testing possible for us to secure private investment. The loan program has helped countless companies grow and expand in Massachusetts. Today, we announce repayment of that loan! Thank you to the Center, Senator Karen Spilka​, and Governor Charlie Baker​ for your support. We will continue to make Massachusetts proud!

March 6, 2017

Elipse Balloon Multi-Center Study Published

We are pleased to announce the publication of our European multi-center trial results in Endoscopy! Thank you to our European investigators and patients who participated in a groundbreaking study on the Elipse Balloon.